|
|
Other links at Articles > Business of Medicine |
| 3. |
Perrigo Says FDA Clears Generic Version of Pepcid
|
|
|
Drugmaker Perrigo Co said the U.S. Food and Drug Administration granted final approval to market a generic version of Pepcid, the antacid produced by Johnson & Johnson and Merck Consumer Pharmaceutical. Reuters Health Information
|
| 4. |
Transplant Drug Linked to Risk for Fetal Harm
|
|
|
Women of childbearing age should be required to use 2 forms of birth control before, during, and after treatment with mycophenolate mofetil and mycophenolic acid. Medscape Medical News
|
| 5. |
Bayer Stops Late-Stage Nexavar Trial
|
|
|
Bayer HealthCare, a U.S. based unit of Bayer AG, said it stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer, after an independent data monitoring committee concluded that the study would not meet its main goal of improved overall survival. Reuters Health Information
|
|
|
